Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

NCT02285218 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02285218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
March 31, 2019
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, non-alcoholic fatty liver disease, type 2 diabetes